Crossmark

Clinical advantages of two vs. three courses of neoadjuvant chemotherapy using docetaxel + cisplatin + 5-fluorouracil to improve preoperative nutritional status and mitigate decreasing skeletal muscle in resectable esophageal cancer

Crossref DOI link: https://doi.org/10.1007/s10147-025-02839-6

Published Online: 2025-07-17

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Matsui, Kazuaki

Miyawaki, Yutaka

Kobayashi, Ryota

Yoshizawa, Masatoshi

Toriumi, Tetsuro

Ebara, Gen

Sato, Hiroshi

Sakuramoto, Shinichi
Funding

Funding for this research was provided by:

Saitama Medical University
License Information

Text and Data Mining valid from 2025-07-17

Version of Record valid from 2025-07-17
More Information

Article History

Received: 13 May 2025

Accepted: 9 July 2025

First Online: 17 July 2025

Declarations

:

: None of the authors have conflicts of interest related to this study.

Document is current

Any future updates will be listed below